FONDAZIONE DI BELLA
>
INDICE DELLA DOCUMENTAZIONE > Area Pazienti - Documentazione
Area Pazienti - Documentazione
In vivo functional and anatomic imaging for assessment of in vivo gene transfer.
(12/04/2011)
Dettaglio
Octreotide for advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
(12/04/2011)
Dettaglio
Refractory recurrent thymoma successfully treated with long-acting somatostatin analogue and prednisolone.
(12/04/2011)
Dettaglio
Inhibition of human non-small cell lung cancers with a targeted cytotoxic somatostatin analog, AN-162.
(12/04/2011)
Dettaglio
Impact of Octreotide and SOM-230 on liver metastasis and hepatic lipidperoxidation in ductal pancreatic adenocarcinoma in Syrian Hamster.
(12/04/2011)
Dettaglio
Somatostatin receptor scintigraphy for optic nerve sheath meningiomas.
(12/04/2011)
Dettaglio
A somatostatin analogue, octreotide, inhibits the occurrence of second primary tumors and lung metastasis after resection of hepatocellular carcinoma in mice
(12/04/2011)
Dettaglio
All-trans retinoic acid suppresses Stat3 signaling during skin carcinogenesis.
(12/04/2011)
Dettaglio
Effects of non-cytotoxic drugs on the growth of multidrug-resistance human gastric carcinoma cell line.
(12/04/2011)
Dettaglio
Visualization of somatostatin receptors in prostate cancer and its bone metastases with Ga-68-DOTATOC PET/CT.
(12/04/2011)
Dettaglio
Octreotide inhibits growth of colonic cancer SW480 cells by modulating the Wnt/P-catenin pathway.
(12/04/2011)
Dettaglio
Peptide receptor radionuclide therapy with (90)Y-DOTATOC in recurrent meningioma.
(12/04/2011)
Dettaglio
Transcriptional activation of the mixed lineage leukemia-p27Kip1 pathway by a somatostatin analogue.
(12/04/2011)
Dettaglio
Treatment of advanced hepatocellular carcinoma with long-acting octreotide: a phase III multicentre, randomised, double blind placebo-controlled study.
(12/04/2011)
Dettaglio
Acyclic retinoid synergises with valproic acid to inhibit growth in human hepatocellular carcinoma cells.
(12/04/2011)
Dettaglio